Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Biomaterials. 2015 May 31;62:176–187. doi: 10.1016/j.biomaterials.2015.05.046

Fig. 5.

Fig. 5

A: The cell-killing effect of CPT-VE, CPT-S-S-VE, PEG5K-Fmoc-VE2/CPT-VE and PEG5K-Fmoc-VE2/CPT-S-S-VE with or without GSH (10 mM) in 4T1.2 cancer cell. Cells were treated with indicated concentrations of different CPT formulations for 72 h and cytotoxicity was then assessed by MTT assay. Values reported are the means ± SD for triplicate samples. B: Intracellular release of CPT in 4T1.2 cells treated with CPT-VE and CPT-S-S-VE (100 ng/mL in terms of CPT) for 24 h.